吉田 一彦
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine
   Position   Assistant Professor
Article types Original article
Language English
Peer review Peer reviewed
Title Time to progression after first-line tyrosine kinase inhibitor predicts survival in patients with metastatic renal cell carcinoma receiving second-line molecular-targeted therapy.
Journal Formal name:Urologic oncology
Abbreviation:Urol Oncol
ISSN code:10781439
Domestic / ForeginForegin
Volume, Issue, Page 35(9),pp.542.e1-542.e9
Author and coauthor ISHIHARA Hiroki†, KONDO Tsunenori*, YOSHIDA Kazuhiko, OMAE Kenji, TAKAGI Toshio, IIZUKA Junpei, TANABE Kazunari
Publication date 2017/09
DOI 10.1016/j.urolonc.2017.05.014